Page last updated: 2024-08-25

methotrexate and Flushing

methotrexate has been researched along with Flushing in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Orr, A; Parker, R	1
Agular, B; Gröndal, G; Hansen, I; Jensen, EC; Johansen, P; Juul, L; Lindegaard, HM; Schlemmer, AM	1
Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y	1

Trials

2 trial(s) available for methotrexate and Flushing

Article	Year
Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious. Scandinavian journal of rheumatology, 2016, Volume: 45, Issue:4 Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Drug Hypersensitivity; Edema; Fatigue; Female; Flushing; Glucocorticoids; Headache; Humans; Hypercholesterolemia; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Nasopharyngitis; Neutropenia; Treatment Outcome; Tumor Necrosis Factor-alpha	2016
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. Bone marrow transplantation, 1995, Volume: 15, Issue:6 Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome	1995

Article

Year

Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious.

Scandinavian journal of rheumatology, 2016, Volume: 45, Issue:4

Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Drug Hypersensitivity; Edema; Fatigue; Female; Flushing; Glucocorticoids; Headache; Humans; Hypercholesterolemia; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Nasopharyngitis; Neutropenia; Treatment Outcome; Tumor Necrosis Factor-alpha

2016

FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.

Bone marrow transplantation, 1995, Volume: 15, Issue:6

Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome

1995

Other Studies

1 other study(ies) available for methotrexate and Flushing

Article	Year
Red clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexate. Menopause international, 2013, Volume: 19, Issue:3 Topics: Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Female; Flushing; Humans; Menopause; Methotrexate; Middle Aged; Plant Extracts; Psoriasis; Trifolium; Withholding Treatment	2013